Lumacaftor Production Cost Reports

The report provides a detailed analysis essential for establishing a Lumacaftor production plant. It encompasses all critical aspects necessary for Lumacaftor production, including the cost of Lumacaftor production, Lumacaftor plant cost, Lumacaftor production costs, and the overall Lumacaftor production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a Lumacaftor production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.

Lumacaftor is a pharmaceutical compound mainly used in the treatment of cystic fibrosis, specifically in patients with the F508del mutation in the CFTR gene. It is most commonly used in combination with ivacaftor as part of a dual therapy that helps improve the function of the defective CFTR protein. Its role is to help the faulty CFTR protein fold correctly so it can reach the cell surface and function more effectively.

This combination enhances chloride transport in cells, which improves lung function and reduces respiratory complications. It also plays a significant role in pharmaceutical research, particularly in drug development based on protein misfolding diseases. It is also used in research settings to study CFTR protein behaviour and to support the development of improved next-generation modulators for cystic fibrosis care.

The market for Lumacaftor is mainly driven by its use as a drug for the treatment of cystic fibrosis, which significantly boosts its demand in the medical sector. Its application in combination with ivacaftor to improve lung function and reduce disease complications in patients with the F508del mutation also fuels its demand in the pharmaceutical industry. Rising awareness, diagnosis rates, and access to advanced treatments, along with their importance in long-term therapy for cystic fibrosis, further boost its market growth. Its usage for improving breathing, reducing lung flare-ups, and helping maintain better respiratory health over time also drives its demand in the medical and healthcare sectors.

Its involvement as a tool compound for understanding CFTR modulation in cellular models also contributes to its demand in the pharmaceutical research industry. Additionally, industrial Lumacaftor procurement is influenced by factors such as the cost and steady availability of specialised intermediates, strict regulatory standards for drug production, and compliance with safety and environmental guidelines. Advancements in synthesis methods, reliable supplier networks, and efficient global distribution also play a major role in shaping procurement practices and supporting the overall market for Lumacaftor.

Raw Material for Lumacaftor Production

According to the Lumacaftor production plant project report, the major raw materials for Lumacaftor production include 1-(2,2-difluoro-1,3-benzodioxol-5-yl)cyclopropane-1-carboxylic acid and 3-(6-amino-3-methylpyridin-2-yl)benzoic acid.

Production Process of Lumacaftor

The extensive Lumacaftor production cost report consists of the following industrial production process:

1. Production via Formal Condensation Reaction: The production process of Lumacaftor begins with the preparation of two key intermediates, including 1-(2,2-difluoro-1,3-benzodioxol-5-yl)cyclopropane-1-carboxylic acid and 3-(6-amino-3-methylpyridin-2-yl)benzoic acid. These compounds are synthesised separately using aromatic substitution and cyclopropanation steps. Once both intermediates are ready, they undergo a condensation reaction where the carboxylic acid group of the cyclopropane derivative reacts with the aromatic amino group of the benzoic acid derivative. The reaction forms an amide bond, which results in the formation of Lumacaftor as the final product, which is further subjected to purification steps like crystallisation or chromatography.

Lumacaftor is a crystalline white to off-white solid with no distinct odour. It is used as a pharmaceutical active ingredient and is practically insoluble in water under normal conditions. The molecular formula of the compound is C24H18F2N2O5, and its molar mass is about 452.41 g/mol. It has a density of around 1.5 g/cm3. It is a complex organic compound with a melting point of around 200-205 degree Celsius and a boiling point of 653.0 degree Celsius. It is generally stored in a freezer at -20 degree Celsius. It is soluble in some organic solvents, such as DMSO and methanol. It is a bioactive chemical, and it should be handled with appropriate protective measures because it can cause irritation and other health effects if mishandled.